Up-regulation of lipocalin 2 is associated with high-risk human papillomavirus and grade of cervical lesion at baseline but does not predict outcomes of infections or incident cervical intraepithelial neoplasia

American Journal of Clinical Pathology

Volumn 134, Issue 1, 2010, Pages 50-59

  Syrjänen, Stina ^a   Naud, Paulo ^b   Sarian, Luis ^c   Derchain, Sophie ^c   Roteli Martins, Cecilia ^d   Tatti, Silvio ^e   Branca, Margerita ^f   Eržen, Mojca ^g   Hammes, Luciano S ^b   Costa, Silvano ^h   Longatto Filho, Adhemar ^i,j   Syrjänen, Kari ^k  

^a UNIVERSITY OF TURKU   (Finland)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^c UNIVERSITY OF CAMPINAS   (Brazil)

^d HOSPITAL MATERNIDADE LEONOR MENDES DE BARROS   (Brazil)

^e HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

^f ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^g SIZE Diagnostic Center   (Slovenia)

^h UNIVERSITY OF BOLOGNA   (Italy)

ⁱ INSTITUTO ADOLFO LUTZ   (Brazil)

^j UNIVERSITY OF MINHO   (Portugal)

^k TURKU UNIVERSITY HOSPITAL   (Finland)

more..

Author keywords

Cervical intraepithelial neoplasia; Disease progression; High risk human papillomavirus; LCN2; Lipocalins; Longitudinal predictive values; Neutrophil gelatinase associated lipocalin; NGAL; Surrogate end points; Viral outcomes

Indexed keywords

NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; PROTEIN E6; PROTEIN P53; VIRUS LARGE T ANTIGEN;

ARTICLE; CANCER SCREENING; CONDYLOMA ACUMINATUM; CONTROLLED STUDY; DISEASE COURSE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFECTION RISK; NONHUMAN; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIMIAN VIRUS 40; UPREGULATION; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA IN SITU; VIRUS DETECTION; VIRUS LOAD; WART VIRUS;

ACUTE-PHASE PROTEINS; CERVICAL INTRAEPITHELIAL NEOPLASIA; DNA, VIRAL; FEMALE; HUMANS; LATIN AMERICA; LIPOCALINS; MASS SCREENING; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROTO-ONCOGENE PROTEINS; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 77954460356     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1309/AJCP90IKJNQLSNRB     Document Type: Article

References (43)

1. zur Hausen H. Papillomaviruses in the causation of human cancers: a brief historical account. Virology. 2009;384:260-265.
2. Syrjänen KJ. Biology of human papillomavirus (HPV) infections and their role in squamous cell carcinogenesis. Med Biol. 1987;65:21-39. (Pubitemid 17067729)
3. Syrjänen K, Syrjänen S. Papillomavirus Infections in Human Pathology. New York, NY: Wiley; 2000.
4. Syrjänen S, Syrjänen K. The history of papillomavirus research. Cent Eur J Public Health. 2008;16(suppl):S7-S13.
5. Munoz N, Bosch FX, de Sanjose S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348:518-527. (Pubitemid 36159887)
6. Cliffort GM, Gallus S, Herrero R, et al. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: pooled analysis. Lancet. 2005;366:991-998.
7. Syrjänen SM, Syrjänen KJ. New concepts on the role of human papillomavirus in cell cycle regulation. Ann Med. 1999;31:175-187. (Pubitemid 29304455)
8. von Knebel Doeberitz M. New markers for cervical dysplasia to visualise the genomic chaos created by aberrant oncogenic papillomavirus infections. Eur J Cancer. 2002;38:2229-2242.
9. Munger K, Baldwin A, Edwards KM, et al. Mechanisms of human papillomavirus-induced oncogenesis. J Virol. 2004;78:11451-11460.
10. INK4A expression is related to grade of CIN and high-risk human papillomavirus but does not predict virus clearance after conization or disease outcome. Int J Gynecol Pathol. 2004;23:354-365.
11. CIP1/WAF1, cyclin-A in predicting CIN, high-risk human papillomavirus infections and their outcome in women screened in three New Independent States of the Former Soviet Union. Cancer Epidemiol Biomarkers Prevent. 2006;15:1250-1256.
12. Branca M, Ciotti M, Giorgi C, et al. Predicting high-risk human papillomavirus (HPV) infection, progression of cervical intraepithelial neoplasia (CIN) and prognosis of cervical cancer with a panel of 13 biomarkers tested in multivariate modelling. Int J Gynecol Pathol. 2008;27:265-273.
13. Xu S, Venge P. Lipocalins as biochemical markers of disease. Biochim Biophys Acta. 2000;1482:298-307.
14. Flower DR. The lipocalin protein family: a role in cell regulation. FEBS Lett. 1994;354:7-11.
15. Bratt T. Lipocalins and cancer. Biochim Biophys Acta. 2000;1482:318-326.
16. Flower DR. The lipocalin protein family: structure and function. Biochem J. 1996;318(pt 1):1-14. (Pubitemid 26283618)
17. Breustedt DA, Schönfeld DL, Skerra A. Comparative ligand-binding analysis of ten human lipocalins. Biochim Biophys Acta. 2006;1764:161-173.
18. Devarajan P. Neutrophil gelatinase-associated lipocalin: new paths for an old shuttle. Cancer Ther. 2007;5:463-470.
19. Hraba-Renevey S, Turler H, Kress M, et al. SV40-induced expression of mouse gene 24p3 involves a post-transcriptional mechanism. Oncogene. 1989;4:601-608. (Pubitemid 19139712)
20. Xu SY, Carlson M, Engstrom A, et al. Purification and characterization of a human neutrophil lipocalin (HNL) from the secondary granules of human neutrophils. Scand J Clin Lab Invest. 1994;54:365-376. (Pubitemid 24246789)
21. Stoesz SP, Friedl A, Haag JD, et al. Heterogeneous expression of the lipocalin NGAL in primary breast cancers. Int J Cancer. 1998;79:565-572.
22. Nielsen BS, Borregaard N, Bundgaard JR, et al. Induction of NGAL synthesis in epithelial cells of human colorectal neoplasia and inflammatory bowel diseases. Gut. 1996;38:414-420. (Pubitemid 126423216)
23. Furutani M, Arii S, Mizumoto M, et al. Identification of a neutrophil gelatinase-associated lipocalin mRNA in human pancreatic cancers using a modified signal sequence trap method. Cancer Lett. 1998;122:209-214.
24. Bartsch S, Tschesche H. Cloning and expression of human neutrophil lipocalin cDNA derived from bone marrow and ovarian cancer cells. FEBS Lett. 1995;357:255-259.
25. Cho H, Kim JH. Lipocalin2 expressions correlate significantly with tumor differentiation in epithelial ovarian cancer. J Histochem Cytochem. 2009;57:513-521.
26. Monier F, Mollier S, Guillot M, et al. Urinary release of 72 and 92 kDa gelatinases, TIMPs, N-GAL and conventional prognostic factors in urothelial carcinomas. Eur Urol. 2002;42:356-363.
27. Zhang H, Xu L, Xiao D, et al. Upregulation of neutrophil gelatinase-associated lipocalin in oesophageal squamous cell carcinoma: significant correlation with cell differentiation and tumour invasion. J Clin Pathol. 2007;60:555-561.
28. Kubben FJ, Sier CF, Hawinkels LJ, et al. Clinical evidence for a protective role of lipocalin-2 against MMP-9 autodegradation and the impact for gastric cancer. Eur J Cancer. 2007;43:1869-1876.
29. Iannetti A, Pacifico F, Acquaviva R, et al. The neutrophil gelatinase-associated lipocalin (NGAL), a NF-kappaBregulated gene, is a survival factor for thyroid neoplastic cells. Proc Natl Acad Sci U S A. 2008;105:14058-14063.
30. Syrjänen K, Naud P, Derchain SM, et al. Comparing Pap smear cytology, aided visual inspection, screening colposcopy, cervicography and HPV testing as optional screening tools in Latin America: study design and baseline data of the LAMS study. Anticancer Res. 2005;25:3469-3480.
31. Longatto-Filho A, Maeda MYS, Eržen M, et al. Conventional Pap smear and liquid-based cytology as screening tools in low-resource settings of Latin America: experience of the Latin American Screening study. Acta Cytol. 2005;49:500-506.
32. Sarian L, Derchain SM, Naud P, et al. Evaluation of visual inspection with acetic acid (VIA), Lugol's iodine (VILI) cervical cytology and HPV testing as cervical screening tools in Latin America: this report refers to partial results from the LAMS (Latin American Screening) study. J Med Screen. 2005;12:142-149.
33. Longatto-Filho A, Eržen M, Branca M, et al. Human papillomavirus (HPV) testing as an optional screening tool in low-resource settings of Latin America: experience from the LAMS study. Int J Gynecol Cancer. 2006;16:955-962.
34. Syrjänen K, Shabalova I, Naud P, et al. Persistent high-risk human papillomavirus (HPV) infections and other end-point markers of progressive cervical disease among women prospectively followed-up in the New Independent States of the Former Soviet Union and Latin American Screening study cohorts. Int J Gynecol Cancer. 2009;19:934-942.
35. Seed PT, Tobias A. Summary statistics for diagnostic tests. Stata Tech Bull. 2001;10:9-12.
36. Fernandez CA, Yan L, Louis G, et al. The matrix metalloproteinase-9/ neutrophil gelatinase-associated lipocalin complex plays a role in breast tumor growth and is present in the urine of breast cancer patients. Clin Cancer Res. 2005;11:5390-5395.
37. Yan L, Borregaard N, Kjeldsen L, et al. The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B/MMP-9 and neutrophil gelatinase-associated lipocalin (NGAL): modulation of MMP-9 activity by NGAL. J Biol Chem. 2001;276:37258-37265.
38. Branca M, Giorgi C, Santini D, et al. Aberrant expression of vascular endothelial growth factor-C (VEGF-C) is related to grade of cervical intraepithelial neoplasia (CIN) and high-risk human papillomavirus (HPV), but does not predict virus clearance after treatment of CIN or prognosis of cervical cancer. J Clin Pathol. 2006;59:40-47. (Pubitemid 43076237)
39. Branca M, Giorgi C, Ciotti M, et al. Matrix metalloproteinase-2 (MMP-2) and its tissue inhibitor (TIMP-2) are prognostic factors in cervical cancer, related to invasive disease but not to high-risk human papillomavirus (HPV) or virus persistence after treatment of CIN. Anticancer Res. 2006;26:1543-1556.
40. Human Protein Atlas Web site. http://www.proteinatlas.org/. Accessed May 20, 2010.
41. Lee JH, Kye KC, Seo EY, et al. Expression of neutrophil gelatinase-associated lipocalin in calcium-induced keratinocyte differentiation. J Korean Med Sci. 2008;23:302-306.
42. Moniaux N, Chakraborty S, Yalniz M, et al. Early diagnosis of pancreatic cancer: neutrophil gelatinase-associated lipocalin as a marker of pancreatic intraepithelial neoplasia. Br J Cancer. 2008;98:1540-1547. (Pubitemid 351652327)
43. Branca M, Giorgi C, Santini D, et al. Aberrant expression of a novel inhibitor of apoptosis (survivin) is related to grade of cervical intraepithelial neoplasia (CIN), but does not predict virus clearance after cone or prognosis in cervical cancer. Am J Clin Pathol. 2005;124:113-121.